Health ministry decides against including Itolizumab in clinical management protocols for COVID-19 Read more
US DOJ permits six drug makers to share info about COVID-19 MAb treatments to expedite production Read more
Jenburkt Pharmaceuticals second in India to launch Favipiravir (FaviventTM) to fight COVID-19 Read more
Glenmark announces top-line results from Phase 3 clinical trial of favipiravir for COVID-19 treatment Read more